# Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

> **NCT00137111** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 501 (actual)

## Conditions studied

- Lymphoblastic Leukemia, Acute

## Interventions

- **DRUG:** Prednisone, Dexamethasone, Vincristine, Daunorubicin
- **DRUG:** Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase
- **DRUG:** Methotrexate, Cyclophosphamide, Cytarabine, Etoposide
- **DRUG:** Mercaptopurine, Imatinib
- **PROCEDURE:** chemotherapy, intrathecal chemotherapy
- **PROCEDURE:** steroid therapy, hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT00137111
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07-08
- **Primary completion:** 2010-11
- **Final completion:** 2014-04
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2020-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137111, "Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00137111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*